Reimbursement
As many practices move from planning for to actually implementing the new code set for the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), a few things are strikingly apparent. Read More ›
One of the most vital roles of the oncology practice manager and financial assistance staff is managing patient affordability issues for oncologic therapies. Preventing patient sticker shock is essential to avoiding any disruption of therapy and the imposition of additional emotional burden on the patient and family. Read More ›
The American healthcare system is clearly evolving. Although dramatic changes are likely, these changes will be neither instant nor universal. Thus, to optimize revenue, it remains extremely important to understand the current reimbursement situation Read More ›
As most of us know, poor previsit processes create havoc on a practice's ability to post, bill, and collect for services rendered. A previsit process that is laden with errors, variation, and waste will result in an increase not only in denials and lost revenue, but also in cost associated with catching and correcting errors on the back end. Read More ›
The deadline for going live with the International Classification of Diseases (ICD), 10th edition is October 1, 2013, and the Centers for Medicare & Medicaid Services repeatedly has attested this as a firm deadline with no extensions, delays, or grace periods. Read More ›